1
0
0
News
Netzwerk-Profile
LinkedIn: Hakim Echchannaoui | Berufsprofil - LinkedIn
weltweit größten beruflichen Netzwerk. Hakim Echchannaoui hat 1 Job im Profil
angegeben. Sehen Sie sich auf LinkedIn das vollständige Profil an und erfahren
Sie mehr über die Kontakte von Hakim Echchannaoui und über Jobs bei
ähnlichen ...
LinkedIn: Hakim Echchannaoui - 博士后- Johannes Gutenberg-Universität ...
上领英，在全球领先职业社交平台查看Hakim Echchannaoui的职业档案。Hakim的职业档案列出了1 个职位。查看Hakim的完整档案，结识职场人脉和查看相似公司的职位。
LinkedIn: Hakim Echchannaoui - Post-Doc - Johannes Gutenberg LinkedIn
Germany - Post-Doc - Johannes Gutenberg-Universität, Mainz#####View Hakim Echchannaoui's profile on LinkedIn, the world's largest professional community. Hakim has 1 job listed on their profile. See the complete profile on LinkedIn and discover Hakim's connections and jobs at similar companies.
Hakim Echchannaoui: مفت ڈاؤنلوڈ. ای بک لائبریری۔ Z-Library پر آن ...ur.booksc.me › author
ur.booksc.me
Hakim Echchannaoui: مفت ڈاؤنلوڈ. ای بک لائبریری۔ Z-Library پر آن لائن کتابوں کی دکانیں | BookSC. Download books for free. Find books.
Business-Profile
Hakim ECHCHANNAOUI | Universitätsmedizin der Johannes Gutenberg...
www.researchgate.net
Hakim Echchannaoui Markus Munder Interfering with tumor metabolism by specifically restricting the availability of extracellular nutrients is a rapidly emerging field of cancer research.
Bücher
Immune Therapy of Lympho-Hemopoietic Malignancies ...ur.booksc.eu › book
ur.booksc.eu
Immune Therapy of Lympho-Hemopoietic Malignancies Hakim Echchannaoui a, b Matthias Theobald a, b a University Cancer Center (UCT), Research Center ...
p53 in the Clinicsbooks.google.com › books
books.google.com
Immunotherapy. of. Cancer. Hakim Echchannaoui and Matthias Theobald. 1. p53: Guardian. of. the. Genome. Cancer is usually associated with deregulated cell ...
Dokumente zum Namen
Echchannaoui, Hakim [WorldCat Identities]worldcat.org › identities
worldcat.org
Most widely held works by Hakim Echchannaoui ... Immune Therapy of Lympho-Hemopoietic Malignancies by Hakim Echchannaoui( )
[PDF] ZORA_NL_ pdfwww.zora.uzh.ch › eprint › ZORA_NL_
www.zora.uzh.ch
Hakim Echchannaoui,1 Karl Frei,3 Christian Schnell,2. Stephen L. Leib,4 Werner Zimmerli,1 and Regine Landmann1. 1Division of Infectious Diseases, ...
Wissenschaftliche Veröffentlichungen
Toll-Like Receptor 2-Deficient Mice Are Highly Susceptible to jstorwww.jstor.org › stable
www.jstor.org
Hakim Echchannaoui,1 Karl Frei,3 Christian Schnell,2. Stephen L. Leib,4 Werner Zimmerli,1 and Regine Landmann1. 1 Division of Infectious Diseases, ...
Veröffentlichungen allgemein
[PDF] pdf - COREcore.ac.uk › download › pdf
core.ac.uk
Vorgelegt der. Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel von. Hakim Echchannaoui aus Saint-Louis, Frankreich. Basel, August
[PDF] Abstracts BOOK - American Association for Cancer Research (AACR)www.aacr.org › uploads › › Abstract-book-FINAL1
www.aacr.org
Site Frankfurt/Mainz, Germany), Hakim Echchannaoui (Internal. Medicine III, University Cancer Center (UCT), Research Center.
Sonstiges
EP B1 - Nouveaux antigènes associés aux tumeurs ...patents.google.com › patent
patents.google.com
... Fatho: Daniela Eberts: Hakim ECHCHANNAOUI: Volker Lennerz: Catherine WÖLFEL: Thomas Wölfel; Current Assignee (The listed assignees may be inaccurate.
III. Medizinische Klinik - Arbeitsgruppe Echchannaoui/Theobald |...
www.unimedizin-mainz.de
Principal Investigators. Dr. phil. nat. Hakim Echchannaoui. Funktionen: Senior Research Scientist Kontakt aufnehmen. Univ.-Prof. Dr. med. Matthias Theobald. Funktionen: Director of the Department of Hematology, Oncology, and Pneumology, Deputy director of the University Cancer Center Mainz (UCT Mainz)
616. Acute Myeloid Leukemias: Investigational Therapies, Excluding ...ash.confex.com › ash › webprogram › Session22807
ash.confex.com
... Catharina Lahrmann1*, Kerstin Kunz1*, Linda Kessler, BA3*, Hakim Echchannaoui, PhD1*, Chun-Wei David Chen, PhD4, Thomas Kindler, MD5*, Francis Burrows, ...
Adoptiver Immuntransfer und CAR-T-Zellen bei malignen ...www.semanticscholar.org › paper › Adoptiver-Imm...
www.semanticscholar.org
Hakim Echchannaoui, K. Dietrich, M. Theobald; Published 21 August 2017; Medicine; Der Onkologe. ZusammenfassungHintergrundDie adoptive Zelltherapie (ACT) ...
Investigating T Cell Immunity in Cancer: Achievements and Prospectswww.mdpi.com › review_report
www.mdpi.com
Reviewer 2: Hakim Echchannaoui. Int. J. Mol. Sci , 22(6), 2907; https://doi.org ijms Received: 19 January Revised: 4 March
The Interleukin-10 Signal Transduction Pathway and Regulation of ...www.liebertpub.com › doi › pdfplus
www.liebertpub.com
Maryse Letiembre, Hakim Echchannaoui, Fabrizia Ferracin, Serge Rivest, Regine Landmann Toll- like receptor-2 deficiency is associated with enhanced ...
The Δ133p53 Isoforms, Tuners of the p53 Pathway - OUCIouci.dntb.gov.ua › works
ouci.dntb.gov.ua
... Danuta Galetzka, Borhane Guezguez, Michael Hundemer, Jean-Christophe Bourdon, Markus Munder, Matthias Theobald, Hakim Echchannaoui.
Toll-Like Receptor 2 Deficiency Delays ASM Journalsjournals.asm.org › ... › Vol. 73, No. 12
journals.asm.org
Authors: Maryse Letiembre, Hakim Echchannaoui, Philipp Bachmann, Fabrizia Ferracin, Concepción Nieto, Manuel Espinosa, Regine Landmann [email ...
Toll-Like Receptor 2 Deficiency Delays Pneumococcal Phagocytosis ...www.academia.edu › Toll_Like_Receptor_2_Defici...
www.academia.edu
Toll-Like Receptor 2 Deficiency Delays Pneumococcal Phagocytosis and Impairs Oxidative Killing by Granulocytes Maryse Letiembre,1† Hakim Echchannaoui,1† ...
Western blotting —Bio-101cn.bio-protocol.org › bio101
cn.bio-protocol.org
... Borhane Guezguez MH Michael Hundemer JB Jean-Christophe Bourdon MM Markus Munder MT Matthias Theobald HE Hakim Echchannaoui. 本实验方法提取自研究论文：
[PPT]
www.jni-journal.com
Maryse Letiembre, Hakim Echchannaoui, Fabrizia Ferracin, Serge Rivest, Regine Landmann. Journal of Neuroimmunology. Volume 168 Issue 1 Pages (November ...
ijms xml - MDPImdpi-res.com › d_attachment › ijms › ijms › article_deploy › ij...
mdpi-res.com
... Soo Seo Shilpa Singh Hakim Echchannaoui Shilpa Thakur Halil İbrahim Çiftçi Shimeles Tilahun Hamid Badali Shimi Meleppattu Hamid Maadi Shimpei Higo Hamza ...
p53-specific T cell receptor - [scite report]scite.ai › reports
scite.ai
A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo · Hakim Echchannaoui 1,. Jutta Petschenka.
Association cantonale vaudoise de football - Match center - SFVmatchcenter-acvf.football.ch › ...
matchcenter-acvf.football.ch
· Hakim Echchannaoui ? 12. Essaid Tamtam ? Remplaçants Donato Stefanelli. 7. Edouard Demont. 9. Kais Roger Riahi. 4. Nenad Berbatovic.
Cited By Cancer Research and Treatmentwww.e-crt.org › journal › CitedBy
www.e-crt.org
· Anke Werner, Daniel Pieh, Hakim Echchannaoui, Johanna Rupp, Krishnaraj Rajalingam, Matthias Theobald, Ellen I. Closs, Markus Munder.
LFA-1 on CD4+ T Cells Is Required for Optimal Antigen-Dependent ...www.jimmunol.org › content › tab-article-info
www.jimmunol.org
· Julian Plaumann, Melanie Engelhardt, Mohamed H. S. Awwad, Hakim Echchannaoui, Eva Amman, Marc S. Raab, Jens Hillengass, Niels Halama, ...
Verwandte Suchanfragen zu Hakim Echchannaoui
| Regine Landmann Daniel Pieh Anke Werner | Johanna Rupp |
Personen Vorname "Hakim" (734) Name "Echchannaoui" (1) |
sortiert nach Relevanz / Datum